Do you want to read an article? Please log in or register.
Rescue of the CFTR chloride channel with nonsense mutations is markedly improved under inflammatory conditions
Pulmonary Fibrosis
Related content
Pulmonary Fibrosis
Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis
Eur Respir J
Berger J, Yu Y, Berges J, González A, Rossow V, Hämmerling S, Morty RE, Thee S, Stahl M, Sommerburg O, Mall MA, Graeber SY
doi: 10.1183/13993003.00422-2026
Pulmonary Fibrosis
CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial
Nat Commun
Knoll RL, Brauny MM, Robert E, Cloos L, Waser L, Hilbert K, Ulmer N, Hillen B, Birkner T, Bartolomaeus TUP, Nitsche O, Jarquín-Díaz VH, Lynch S, Gehring S, Maier L, Poplawska K, Forslund-Startceva SK
doi: 10.1038/s41467-025-64218-z
RECOMMENDED
Pulmonary Fibrosis
Research and optimization of screening strategy for calcium-activated chloride channel modulators guided by electrophysiological characteristics
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Wang Y, Zheng K, Yang L, Liu L, Han H, Chen S, Qu Z, Qin K, Zhang W, Hao F
doi: 10.1038/s41598-026-39762-3
Lung Cancer
KRAS G12C Mutation Predicts Improved Survival in NSCLC Patients Receiving Immunotherapy: Insights from a Real-World Cohort
J Clin Med
Geçgel A, Şahin Çelik B, Peker P, Gökdere ZS, Koca D, Karaca B, Nart D, Göker E
doi: 10.3390/jcm14196826
Lung Cancer
Activating KRAS mutations mark premalignant cystic structures in congenital pulmonary airway malformations
Respir Res
van Horik C, Benthem F, Buscop-van Kempen M, Boerema-de Munck A, van IJcken WFJ, Wijnen RMH, Schnater M, Rottier RJ
doi: 10.1186/s12931-025-03491-4
Pulmonary Fibrosis
Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12-Month Phased Project at Ain Shams University
Pediatr Pulmonol
Hussein MM, Nasr SZ, Kamel TB, Rashad M, Kamel DN, Fawzy EA
doi: 10.1002/ppul.71621
RECOMMENDED
Pulmonary Fibrosis
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic Fibrosis
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Chalamalla AR, Baker E, Ryan KJ, Dowell A, Natt JR, Zemanick ET, Konstan MW, Mayer-Hamblett N, Acosta EP, Guimbellot JS, CHEC-SC investigators
doi: 10.1183/13993003.01594-2025
RECOMMENDED
Pulmonary Fibrosis
Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
J Cyst Fibros
Bardin E, Salvator H, Roquencourt C, Lamy E, Hunzinger N, Sermet-Gaudelus I, De Miranda S, Grenet D, Devillier P, Grassin-Delyle S
doi: 10.1016/j.jcf.2026.06.013
RECOMMENDED
Pulmonary Fibrosis
Effectiveness of CFTR modulator therapy on risk of death for individuals with cystic fibrosis
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Kurgansky KE, Collaco JM, Ng DK, Lesko CR
doi: 10.1016/j.chest.2026.04.041